Table 3.
The expected savings and QALYs gained on an individual and population level among 100,399 women and 80,375 men in non-T2D pharmacy visiting population. Comparator for the intervention was current practice
| 10-year time period | 20-year time period | 30-year time period | ||||
|---|---|---|---|---|---|---|
| Women | Men | Women | Men | Women | Men | |
| Expected savings potential per person € (95% CI) | 15 (− 799 to 945) | 268 (− 799 to 1520) | 1031 (− 1002 to 3264) | 1889 (− 1053 to 4846) | 1457 (− 1085 to 4024) | 2115 (− 816 to 5239) |
| Expected savings potential per person Only direct costs € (95% CI) | − 410 (− 738 to − 39) | − 228 (− 738 to 343) | 625 (− 1012 to 2472) | 1264 (− 1105 to 3601) | 1044 (− 967 to 3107) | 1526 (− 1133 to 3920) |
| Expected gained QALYs per person (95% CI) | 0.0031 (−0.0004 to 0.0074) | 0.0055 (− 0.0008 to 0.0133) | 0.0270 (− 0.0054 to 0.0623) | 0.0538 (− 0.010 to 0.1230) | 0.0684 (− 0.0141 to 0.1512) | 0.0877 (− 0.0102 to 0.1904) |
| Expected savings potential, population m€ (95% CI) | 1.5 (−80.2 to 94.9) | 21.5 (−64.3 to 122.1) | 103.5 (− 100.5 to 327.7) | 151.8 (− 84.7 to 389.5) | 146.2 (− 108.9 to 404.0) | 170.0 (− 65.6 to 421.1) |
| Expected savings potential, population Only direct costs m€ (95% CI) | − 41.2 (− 74.1 to − 3.9) | −18.3 (− 59.4 to 27.6) | 62.7 (− 101.6 to 248.2) | 101.6 (− 88.8 to 289.4) | 104.9 (− 97.1 to 312.0) | 122.9 (− 91.1 to 315.0) |
| Expected gained QALYs, population (95% CI) | 309 (−43 to 738) | 445 (−61 to 1068) | 2712 (− 540 to 6257) | 4320 (− 804 to 9886) | 6869 (− 1418 to 15,178) | 8979 (− 435 to 19,239) |
| Net monetary benefit, cost-effectiveness threshold of 50,000 €/QALY (€) (95% CI) | 170 (− 819 to 1315) | 543 (− 839 to 2185) | 2381 (− 1272 to 6379) | 4579 (− 1553 to 10,996) | 4877 (− 1790 to 11,584) | 6500 (− 1326 to 14,759) |
CI Confidence interval, QALY Quality-adjusted life year